| Today, Tue, Nov 24, 2009 | | • | H-P: Analysts' Upgrades, Downgrades
at TheStreet.com (Tue 9:24am)
| | • | Cephalon upgraded by Jefferies & Co
Briefing.com (Tue 4:00am)
| | • | [$$] Verizon Advances 3%; Chevron, Exxon Rise
at The Wall Street Journal Online (Tue 12:05am)
| | Mon, Nov 23, 2009 | | • | [$$] Stocks in the Spotlight Monday
at Barrons.com (Mon 5:02pm)
| | • | CEPHALON INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and E
EDGAR Online (Mon 5:01pm)
| | • | [$$] The Good News and the Bad News
at The Wall Street Journal Online (Mon 4:54pm)
| | • | Monday Options Recap
at Seeking Alpha (Mon 3:45pm)
| | • | Nov. 23: Unusual Volume Leaders
at CNBC (Mon 2:17pm)
| | • | UPDATE - Cephalon stock drops after mixed drug trial data
at Reuters (Mon 11:02am)
| | • | Early-Market Movers: Origin Agritech Limited, Ciena Corp
at Fox Business (Mon 10:38am)
| | • | Drug stocks advance; Cephalon falls on study
at MarketWatch (Mon 9:52am)
| | • | A Big Upgrade for Allos Therapeutics
at Motley Fool (Mon 9:16am)
| | • | Mixed results from Ception, Cephalon on Cinquil
at bizjournals.com (Mon 9:05am)
| | • | Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
PR Newswire (Mon 8:00am)
| | Sun, Nov 22, 2009 | | • | Valeant may fall if new drug disappoints-Barron's
at Reuters (Sun, Nov 22)
| | Fri, Nov 20, 2009 | | • | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst
Wall Street Transcript (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | • | CEPHALON INC Files SEC form 8-K, Other Events
EDGAR Online (Thu, Nov 19)
| | Wed, Nov 18, 2009 | | • | Judges: Seattle biotech can pursue $23M claim
AP (Wed, Nov 18)
| | • | Biotech Stocks for a Possible Year-End Rally
at Seeking Alpha (Wed, Nov 18)
| | Mon, Nov 16, 2009 | | • | The Hottest Sector for 2010
at Motley Fool (Mon, Nov 16)
|
Add CEPH News to My Yahoo!:
 
| |
|
0.35% Nasdaq 
0.53 (0.97%) 
Headlines
